ArticleFrontiers in surgery2026
Case Report: Unicentric Castleman disease at the superior border of the pancreatic body mimicking a pancreatic neuroendocrine tumor: a case report and literature review.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripancreatic unicentric Castleman disease is rare and may mimic a primary pancreatic neoplasm because it often presents as a well-circumscribed hypervascular mass. We report a 26-year-old woman with type 2 diabetes mellitus in whom an incidentally detected upper abdominal mass was initially considered to arise from the pancreatic body. Computed tomography and magnetic resonance imaging showed a sharply marginated hypervascular lesion with diffusion restriction at the superior border of the pancreatic body, leading to a preoperative suspicion of pancreatic neuroendocrine tumor. Laparoscopic exploration revealed a well-encapsulated mass in the lesser sac closely abutting the superior surface of the pancreas. A clear dissection plane between the lesion and the pancreatic parenchyma allowed complete excision without pancreatic resection or splenectomy. Histopathological examination confirmed hyaline vascular-type unicentric Castleman disease. The postoperative course was uneventful, and no residual or recurrent lesion was detected during 1 year of follow-up; glycemic status also remained stable. This case highlights that close proximity of a hypervascular mass to the pancreas does not necessarily indicate pancreatic origin. Careful multiplanar imaging and direct intraoperative assessment of the lesion-pancreas interface may help determine the appropriate surgical extent and avoid unnecessary pancreatic resection when complete excision is technically feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.